Company overview
Metrion Biosciences is a UK-based contract research organization specializing in preclinical ion channel drug discovery services for pharmaceutical and biotech clients worldwide. They offer comprehensive solutions from high-throughput screening using advanced platforms like FLIPR Penta and Sophion Qube 384 to IND-enabling studies, cardiac safety profiling, and neuroscience research. Their capabilities include automated electrophysiology, fluorescence-based assays, and work with human stem cells and native tissues from a single research hub.
Metrion is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include ion channel screening, drug discovery cro, cardiac safety, high throughput screening, electrophysiology services.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Metrion include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://metrionbiosciences.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- ion channel screening, drug discovery cro, cardiac safety, high throughput screening, electrophysiology services
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What ion channel screening capabilities does Metrion offer?
- Metrion provides high-throughput screening in 384-well formats using FLIPR Penta for fluorescence-based assays and Sophion Qube 384 for automated electrophysiology, alongside QPatch systems and low-volume liquid handling.
- What therapeutic areas does Metrion support?
- Metrion specializes in cardiac safety profiling, neuroscience research, and ion channel drug discovery, including work with human stem cells and native tissues for translational studies.
- Where is Metrion located and does it serve global clients?
- Metrion operates from a single state-of-the-art research hub in the UK and delivers services to pharmaceutical and bioscience customers worldwide.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
